pivalyloxymethyl butyrate has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, A; Irwin, D; Keer, H; Lipera, W; Lum, B; Natale, R; Paroly, W; Reid, T; Scappaticci, F; Sreedharan, S; Valone, F | 1 |
| Gridelli, C; Maione, P; Rossi, A | 1 |
1 review(s) available for pivalyloxymethyl butyrate and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Butyrates; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Lung Neoplasms; Panobinostat; Phenylenediamines; Vorinostat | 2008 |
1 trial(s) available for pivalyloxymethyl butyrate and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Butyrates; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Fatigue; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Survival Analysis | 2004 |